Soluble HMGB1 Is a Novel Adipokine Stimulating IL-6 Secretion through RAGE Receptor in SW872 Preadipocyte Cell Line: Contribution to Chronic Inflammation in Fat Tissue-Reference-Cited by-同舟云学术

Soluble HMGB1 Is a Novel Adipokine Stimulating IL-6 Secretion through RAGE Receptor in SW872 Preadipocyte Cell Line: Contribution to Chronic Inflammation in Fat Tissue

Published:2013-09-20 Issue:9 Volume:8 Page:e76039
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nativel Brice,Marimoutou Mery,Thon-Hon Vincent G.,Gunasekaran Manoj Kumar,Andries Jessica,Stanislas Giovédie,Planesse Cynthia,Da Silva Christine Robert,Césari Maya,Iwema Thomas,Gasque Philippe,Viranaicken Wildriss

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference57 articles.

1. HMG1 and 2: architectural DNA-binding proteins;JO Thomas;Biochem Soc Trans,2001

2. HMG1 and 2, and related 'architectural' DNA-binding proteins;JO Thomas;Trends Biochem Sci,2001

3. HMGB1: endogenous danger signaling;JR Klune;Mol Med,2008

4. HMGB1 is a therapeutic target for sterile inflammation and infection;U Andersson;Annu Rev Immunol,2011

5. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils;I Ito;J Biol Chem,2007

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Creeping fat exhibits distinct Inflammation-specific adipogenic preadipocytes in Crohn’s disease;Frontiers in Immunology;2023-12-04

2. HMGB1: a double-edged sword and therapeutic target in the female reproductive system;Frontiers in Immunology;2023-08-18

3. Central and Peripheral Inflammation: A Common Factor Causing Addictive and Neurological Disorders and Aging-Related Pathologies;International Journal of Molecular Sciences;2023-06-13

4. Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy;Endocrine Reviews;2023-03-04

5. The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease;Cardiovascular Research;2022-11-30